MET and cancer: As first reported in 2008 by Stein et al. [5], MACC1 acts as a vital transcriptional regulator of the metastasis-inducing hepatocyte growth factor (HGF)/Met pathway in colon cancer, predicting the risk of metastasis in early cancer stages.